Clinical Trial

COPD Flare-Up Clinic After Severe Exacerbations

Study acronym: FLARE-COPD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective randomized controlled trial evaluates whether a specialized "COPD flare-up clinic service" improves outcomes in patients following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Patients presenting to the emergency department with AECOPD and discharged or hospitalized will be randomized 1:1 to either structured follow-up in a dedicated flare-up clinic or standard follow-up by scheduled telephone interviews. The researches hypothesize that structured follow-up in a specialized clinic will reduce recurrent exacerbations, optimize long-term COPD management, and improve patients' quality of life compared to standard care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-01.
Trial Details
NCT Number NCT07629869
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: AstraZeneca
Conditions COPD, COPD Exacerbation (AECOPD)
Enrollment 240 participants
Start Date 2026-07-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23